跳至主要内容
临床试验/EUCTR2015-005405-36-LT
EUCTR2015-005405-36-LT进行中(未招募)1 期

EFFICACY AND SAFETY ASSESSMENT OF T1580 VERSUS VEHICLE IN DRY EYE DISEASE TREATMENT

aboratoires Théa0 个研究点目标入组 450 人开始时间: 2016年5月17日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
450

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Informed consent signed and dated
  • Menopausal woman.
  • Patient with BILATERAL persistent DED
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 270
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 180

排除标准

  • Presence of an active condition :
  • a. Ocular rosacea, uveitis,
  • b. Abnormal eye lid anatomy, blinking, or naso-lachrymal drainage
  • c. Ocular hypertension or glaucoma requiring an ophthalmic medicinal
  • d. Infectious conjunctivitis, severe blepharitis, and/or progressive
  • Major corneal hypoaesthesia value = 20 mm as measured with a Cochet-
  • Bonnet aesthesiometer.
  • Far best corrected visual acuity (BCVA) worse than or equal to + 0.7
  • Any history of, or active, relevant ocular disorder condition other than
  • those listed above which is likely to interfere with the study results as
  • judged by the investigator at Screening or Baseline visits. Any
  • ophthalmic disease likely to change the assessment of fluctuating
  • blurred vision linked to dry eye disease or may result in a visual acuity
  • deterioration in the following year.
  • Other exclusion criteria are defined in the protocol (Exclusion criteria
  • regarding ocular history, Systemic/non Ophthalmic Exclusion Criteria,
  • Specific Exclusion Criteria Regarding Childbearing Potential Women,
  • Exclusion Criteria Related to General Conditions).

研究者

发起方
aboratoires Théa

相似试验